Cite
HARVARD Citation
de Lédinghen, V. et al. (2018). Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study. Clinical infectious diseases. pp. 1013-1018. [Online].